Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

ROLLS-ROYCE HOLDINGS PLC ORD SH (RR.L)

2026-07-18T07:00:30.057505+00:00

Key Updates

Rolls-Royce Holdings (RR.L) has extended its pullback, declining a further -2.64% since the July 13 report to trade at 1,365.60p. The stock has broken below the July 8 low of 1,398.80p, recording a sequence of lower highs and erasing a portion of its year-to-date gains, which now stand at +18.75%. The investment thesis remains anchored on the UltraFan 30 narrow-body re-entry strategy detailed in the 28 June Financial Times report, though near-term execution risks around funding and partnership requirements have come into sharper focus as the share price weakens.

Current Trend

The primary trend remains positive on a year-to-date basis, with RR.L up +18.75%. However, near-term momentum has deteriorated markedly: the stock is down -5.06% over five days and -1.76% over one month. The break below the 1,398.80p level established on 8 July confirms a lower low, shifting the near-term bias lower. Resistance is now defined by the prior support zone between 1,398.80p and 1,402.60p.

Investment Thesis

The core thesis centres on Rolls-Royce leveraging its operational turnaround—evidenced by record profits of £3.5bn reported in February 2024—to fund a strategic return to the high-volume narrow-body engine market via the UltraFan 30 programme. Successful execution would diversify revenue streams beyond wide-body and defence exposures. This expansion is contingent on securing several billion pounds in investment, UK government backing through the Aerospace Technology Institute, and a manufacturing partner, with planemaker decisions required by 2030.

Thesis Status

The thesis status is unchanged but under pressure. The fundamental drivers—record profitability and the UltraFan 30 development roadmap—remain intact. However, the recent price correction reflects growing investor scrutiny of execution risk, specifically the uncertainty surrounding multi-billion pound funding requirements and partnership negotiations. No new fundamental data has emerged to alter the medium-term trajectory, though the near-term risk profile has increased.

Key Drivers

The principal catalyst remains the UltraFan 30 programme and its associated funding and partnership milestones. According to the Financial Times, Rolls-Royce is pursuing UK government support and a manufacturing partner to compete in the narrow-body market, with engine decisions from Airbus and Boeing expected by 2030. The company secured €64mn from the EU's Clean Aviation Joint Undertaking in March and plans ground tests of a prototype in 2028, targeting a 20 per cent improvement in fuel burn compared with current engines. Competition from CFM International's open-fan design represents a significant market threat.

Technical Analysis

The share price is exhibiting a corrective phase within a broader YTD uptrend. Having failed to hold the 1,402.60p level from the 13 July report, the stock has sold off to 1,365.60p, surpassing the previous near-term floor at 1,398.80p. This establishes a lower-high, lower-low pattern over the past two weeks. Resistance now sits at 1,398.80p–1,402.60p, while the next psychological support level is not explicitly defined by recent data; the +18.75% YTD buffer suggests the broader uptrend structure remains intact, but the 5-day decline of -5.06% indicates accelerating selling pressure that warrants monitoring.

Bull Case

  • Record profitability of £3.5bn reported in February 2024 provides substantial balance-sheet capacity to fund the UltraFan 30 programme and broader strategic initiatives. Source
  • The UltraFan 30 targets the narrow-body successor market for Airbus A320 and Boeing 737 Max families, offering access to a high-volume segment that would materially expand the addressable market. Source
  • The engine architecture targets a 20 per cent improvement in fuel burn versus current engines, aligning directly with airline cost-reduction mandates and regulatory decarbonisation trends. Source
  • Receipt of €64mn from the EU's Clean Aviation Joint Undertaking in March provides non-dilutive funding and external validation of the technology roadmap. Source
  • A defined programme timeline—prototype ground tests in 2028 and planemaker decisions by 2030—creates visible medium-term catalysts for re-rating. Source

Bear Case

  • The programme requires several billion pounds in additional investment, creating significant capital allocation pressure and potential dilution risk at a time when the share price is already correcting. Source
  • Execution is conditional on securing UK government backing via the Aerospace Technology Institute and a manufacturing partner; failure to secure either would likely stall or disqualify the programme. Source
  • CFM International's competing open-fan engine design enjoys incumbent relationships with Airbus and Boeing, presenting a formidable barrier to re-entry for Rolls-Royce. Source
  • Rolls-Royce exited the narrow-body market over a decade ago and must now re-establish technological viability and manufacturing credibility with planemakers from a standing start. Source
  • The 2030 decision deadline creates a compressed timeline; any delays to the 2028 ground-test schedule or partnership negotiations could result in missing the narrow-body replacement cycle. Source
CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.